Investors shouldn’t be apprehensive about the recent facility shutdowns from the biggest cannabis name in Canada, one portfolio manager said.

“It’s a big announcement (but) I don’t think it’s a surprise,” Charles Taerk, CEO of Faircourt Asset Management, a sub-advisor to Ninepoint Partners’ cannabis-focused fund, said in reaction to the shutdown of operations at two key facilities in British Columbia (BC) owned by Canopy Growth (NYSE:CGC,TSX:WEED).


After trading hours on Wednesday (March 4), Canopy confirmed it was closing its facilities in Aldergrove and Delta, BC, eliminating approximately 500 positions.

In an interview with the Investing News Network (INN), Taerk said Canopy’s move to end its operations at these facilities is ultimately a positive one.

He noted that rightsizing plans for Canopy had been previously discussed with the February release of its Q3 2020 results.

In an earnings call with investors and analysts at the time, CEO David Klein said the firm wanted to streamline its business in the coming months.

“Mindful of future market growth, we’re prepared to take initial steps to rightsize our business over the next 90 days,” Klein said during the call.

Aside from cost cutting measures, Taerk said that Canopy’s BC operations were allegedly rife with issues of quality concerns and inconsistency since the company took over the two facilities in 2018.

Canopy, for its part, saw a drop in the open market in Toronto. On Thursday (March 5), shares fell over 5 percent nearing the end of the trading session with prices sitting at C$22.48 as of 2:45 p.m. EST.

The Ontario-based producer also announced it is scraping a plan to build a third greenhouse in Niagara-on-the-Lake and expects to record about C$700 million to C$800 million in pre-tax charges for the quarter ending March 31.

“Today’s decision moves us in this direction, and although the decision to close these facilities was not taken lightly, we know this is a necessary step to ensure that we maintain our leadership position for the long-term,” Klein said in a press release.

Canopy told investors that these recent moves, which were done in order to slim down operations, will aid to “align supply and demand while improving production efficiencies over time.”

The combined size of the two BC facilities comes up to about 3 million square feet of licensed cultivation space, Canopy Growth said, originally retrofitted to keep up with projected demand. In its November MD&A filing, Canopy said they had approximately 5.4 million in licensed cultivation capacity, meaning that the closures have more than halved its production capacity, dropping it by 55.6 percent.

Struggles facing the Canadian cannabis sector, including regulatory hurdles and a small retail space, have somewhat suppressed the industry’s growth.

“Nearly 17 months after the creation of the legal adult-use market, the Canadian recreational market has developed slower than anticipated, creating working capital and profitability challenges across the industry,” Canopy Growth noted.

Canopy plans to focus instead on its outdoor production site for more cost-effective cultivation.

Taerk said these moves by Canopy are indicative of a shift to productivity over size for the industry.

The fund manager mentioned that other larger licensed producers in Canada, such as Aurora Cannabis (NYSE:ACB,TSX:ACB) and HEXO (NYSE:HEXO,TSX:HEXO), were on a quick path to build cultivation.

Now, however, the winners of the space will be the ones that are keen to carefully use capital.

“To be the biggest isn’t necessarily going to make you the most efficient,” he said, adding that some cannabis firms have gone on to become cashflow positive by lowering operation and cultivation costs. “They’re showing shareholders that they are better stewards of capital.”

The pressure felt across the sector is something Taerk said is largely a result of a tight capital market.

“I think that there are many companies that are finding it difficult to operate in this capital constrained environment,” he said. Despite the difficulties, Taerk explained that investors are willing to contribute to companies that can prove they’re generating revenue.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less

 Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.

For more information regarding the Company or the offering, please contact ir@hillstreetbevco.com, or

Keep reading... Show less